What are the missing connections in the signalling pathways that connect EML4-ALK to cancer proliferation and survival, and how can we exploit these in therapy? Over the next few years, we will discover much more about this intriguing oncoprotein and how the combination of different portions of EML4 and ALK affect its behaviour. This evidence concerns the gene EML4 and cancer.